Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron, Propiverine, and Solifenacin for LUTS during BCG
NCT05490082Phase 3Unknown
- Sponsor
- Mansoura University
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron, propiverine, solifenacin in lower urinary tract symptoms (LUTS), sponsored by Mansoura University. Status: unknown.
02
Drugs
mirabegronpropiverinesolifenacin
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT05490082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05490082.